Zobrazeno 1 - 10
of 188
pro vyhledávání: '"Francesco, Salvo"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Disproportionality analyses are the most-commonly used study design used in the post-marketing phase to detect suspected adverse drug reactions in individual case safety reports. Recent years have witnessed an exponential increase in published articl
Externí odkaz:
https://doaj.org/article/27f51b0d95244949849ad51aaf5b244b
Autor:
Pierluigi Francesco Salvo, Alessia Sanfilippo, Gianmaria Baldin, Valentina Iannone, Arturo Ciccullo, Damiano Farinacci, Domenico Benvenuto, Alberto Borghetti, Simona Di Giambenedetto, Francesca Lombardi
Publikováno v:
Travel Medicine and Infectious Disease, Vol 62, Iss , Pp 102757- (2024)
Background: High incidence mpox rates suggest asymptomatic individuals may contribute to virus transmission. We undertook this study to assess the seroprevalence of IgG anti-MPXV in a cohort of asymptomatic PLWH, to analyze the size of the phenomenon
Externí odkaz:
https://doaj.org/article/75e2e50adff7477abd75f1014a9da4b4
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Externí odkaz:
https://doaj.org/article/aec582be32dd49e38260032a9acc09aa
Publikováno v:
Travel Medicine and Infectious Disease, Vol 61, Iss , Pp 102746- (2024)
Externí odkaz:
https://doaj.org/article/e4fc50faf1e74b5a9499d2b7fb1bec31
Autor:
Pierluigi Francesco Salvo, Damiano Farinacci, Francesca Lombardi, Arturo Ciccullo, Enrica Tamburrini, Rosaria Santangelo, Alberto Borghetti, Simona Di Giambenedetto
Publikováno v:
Virology Journal, Vol 20, Iss 1, Pp 1-5 (2023)
Abstract Background In May 2022, a new case of Monkeypox Virus (MPX) was reported in a non-endemic area, the United Kingdom, and since then, the number of confirmed cases in Europe has been increasing until WHO, on May 10 2023, declared that MPOX is
Externí odkaz:
https://doaj.org/article/ca96ff31075a4c258a45e5a6056dae74
Publikováno v:
Pharmaceuticals, Vol 17, Iss 3, p 342 (2024)
Daridorexant (dari), as the first dual orexin receptor antagonist (DORA) marketed in Europe, offers a novel therapeutic approach to insomnia. However, data regarding its real-world safety are scarce. Thus, this study was aimed at assessing its safety
Externí odkaz:
https://doaj.org/article/7d4c954fcfbd4dc595ad457da8a8e611
Publikováno v:
International Journal of Mycobacteriology, Vol 12, Iss 2, Pp 168-174 (2023)
Background: Recognized in 1994 as a global emergency by the World Health Organization, tuberculosis (TB) remains an ongoing health threat. In Cameroon, the mortality rate is estimated at 2.9%. Treatment of multidrug-resistant TB (MDR-TB) defined as t
Externí odkaz:
https://doaj.org/article/ad3d8f7d3f7947a0ae7580110da93c99
Autor:
Louis Letinier, Iris Pujade, Perrine Duthoit, Grégoire Evrard, Francesco Salvo, Cédric Gil‐Jardine, Antoine Pariente
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 6, Pp 1472-1481 (2022)
Abstract The elderly people are increasingly exposed to polymedication and therefore to the risks of drug–drug interactions (DDIs). However, there are few data available on the clinical consequences of these drug combinations. We investigated the i
Externí odkaz:
https://doaj.org/article/a00f39c3d4114a868382d5e2b2f12628
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1420 (2023)
Cannabidiol is the first cannabis-derived drug approved for the treatment of Lennox–Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex. In the current study, we performed a descriptive analysis followed by a disproportionality analys
Externí odkaz:
https://doaj.org/article/4678d4818ea946c0aefba08f16beba99
Autor:
Gianmaria Cammarota, Rosanna Vaschetto, Danila Azzolina, Nello De Vita, Carlo Olivieri, Chiara Ronco, Federico Longhini, Andrea Bruni, Davide Colombo, Claudio Pissaia, Federico Prato, Carlo Maestrone, Matteo Maestrone, Luigi Vetrugno, Tiziana Bove, Francesco Lemut, Elisa Taretto, Alessandro Locatelli, Nicoletta Barzaghi, Martina Cerrano, Enrico Ravera, Christian Zanza, Andrea Della Selva, Ilaria Blangetti, Francesco Salvo, Fabrizio Racca, Yaroslava Longhitano, Annalisa Boscolo, Ilaria Sguazzotti, Valeria Bonato, Francesca Grossi, Federico Crimaldi, Raffaella Perucca, Ester Boniolo, Federico Verdina, Gian Luca Vignazia, Erminio Santangelo, Riccardo Tarquini, Marta Zanoni, Antonio Messina, Matteo Marin, Paola Bacigalupo, Graziana Sileci, Nicolò Sella, Edardo De Robertis, Francesco Della Corte, Paolo Navalesi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus st
Externí odkaz:
https://doaj.org/article/f52f0ee4ddb841aca78990eefd039688